BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15136235)

  • 1. Bcl-6 gene mutations in primary cutaneous B-cell lymphomas.
    Gianelli U; Cerri A; Cassani B; Moneghini L; Raviele PR; Berti E; Bosari S
    Haematologica; 2004 May; 89(5):624-6. PubMed ID: 15136235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent bax gene mutations in B-cell lymphomas.
    Peng H; Aiello A; Packham G; Isaacson PG; Pan L
    J Pathol; 1998 Dec; 186(4):378-82. PubMed ID: 10209486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene mutation analysis of sinonasal lymphomas in Indonesia.
    Kurniawan AN; Hongyo T; Hardjolukito ES; Ham MF; Takakuwa T; Kodariah R; Hoshida Y; Nomura T; Aozasa K
    Oncol Rep; 2006 May; 15(5):1257-63. PubMed ID: 16596195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of mutations in 5'-noncoding region of BCL-6 gene in B-cell non-Hodgkin's lymphomas].
    Min DL; Zhou XY; Yang WT; Sun MH; Lu HF; Zhang TM; Zheng AH; Cao PZ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):238-41. PubMed ID: 15256116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous B cell processes with nodular pattern].
    Chirife AM; Bilbao ER; Giménez L; Marino L
    Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas.
    Pescarmona E; Remotti D; Perez M; Monaco S; Pacchiarotti A; Faraggiana T; Russo G; Baroni CD
    Histopathology; 2006 Oct; 49(4):343-8. PubMed ID: 16978196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
    Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
    Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher frequency of p53 gene mutations in diffuse large B-cell lymphoma with MALT component.
    Tai YC; Tan JA; Peh SC
    Pathol Int; 2004 Nov; 54(11):811-8. PubMed ID: 15533223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the BIK gene in human peripheral B-cell lymphomas.
    Arena V; Martini M; Luongo M; Capelli A; Larocca LM
    Genes Chromosomes Cancer; 2003 Sep; 38(1):91-6. PubMed ID: 12874789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
    Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
    Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas.
    Bertoni F; Conconi A; Luminari S; Realini C; Roggero E; Baldini L; Carobbio S; Cavalli F; Neri A; Zucca E
    Leukemia; 2000 Mar; 14(3):446-8. PubMed ID: 10720140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma.
    Espinet B; Gallardo F; Pujol RM; Estrach T; Servitje O; Solé F
    Haematologica; 2004 Sep; 89(9):ELT14. PubMed ID: 15377491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
    Li T; Zhang B; Ye Y; Yin H
    Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
    Sugita Y; Tokunaga O; Nakashima A; Shigemori M
    Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas.
    Wu JM; Vonderheid E; Gocke CD; Moresi JM; Liegeois N; Borowitz MJ
    J Cutan Pathol; 2012 Oct; 39(10):918-28. PubMed ID: 22845743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.